Cardiomyopathy in pregnancy is rare (1:15,000) and can be extremely hazardous (50%
mortality) with adverse feto-maternal outcomes. Rarity of cases results in lack of common
consensus regarding their management. Descriptively analysing these women will enable
us to understand this condition more clearly
